What's in Huabo Biopharm Co., Ltd.'s pipeline?

Huabo Biopharm Co., Ltd. has 7 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Huabo Biopharm Co., Ltd.'s portfolio?

Top competitors by shared drug class: Pfizer, Bristol-Myers Squibb, Addpharma Inc., Asan Medical Center, Beijing Tiantan Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/huabo-biopharm-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Huabo Biopharm Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Huabo Biopharm Co., Ltd. pipeline: 0 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
HB0025	HB0025	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
HB0017 Q8W	HB0017 Q8W	phase 3	PD-1 inhibitor	PD-1	Oncology
HB0017 Q4W	HB0017 Q4W	phase 3	monoclonal antibody	Unknown	Immunology

Therapeutic area mix

Diabetes · 1
Immunology · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 3 shared drug classes
Bristol-Myers Squibb · 2 shared drug classes
Addpharma Inc. · 2 shared drug classes
Asan Medical Center · 2 shared drug classes
Beijing Tiantan Hospital · 2 shared drug classes
BioRay Pharmaceutical Co., Ltd. · 2 shared drug classes
Ahn-Gook Pharmaceuticals Co.,Ltd · 2 shared drug classes
Avalo Therapeutics, Inc. · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Huabo Biopharm Co., Ltd.:

Cite this brief

Drug Landscape (2026). Huabo Biopharm Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/huabo-biopharm-co-ltd. Accessed 2026-05-16.